Tin tức & Cập nhật
Lọc theo Chuyên ngành:
What is the ideal number of NACT cycles for muscle invasive bladder cancer?
Four cycles of neoadjuvant chemotherapy (NACT) results in better pathological response and survival than three NACT cycles in patients with muscle invasive bladder cancer, reveals a recent study.
What is the ideal number of NACT cycles for muscle invasive bladder cancer?
06 Jan 2022Robotic-assisted radical cystectomy for bladder cancer: Intracorporeal urinary diversion of benefit
Intracorporeal urinary diversion (ICUD) is associated with similar postoperative complication rates, reduced blood loss and shorter hospitalization vs extracorporeal urinary diversion (ECUD) in patients undergoing robotic-assisted radical cystectomy (RARC) for localized bladder cancer, data from the Asian RARC Consortium registry have shown.
Robotic-assisted radical cystectomy for bladder cancer: Intracorporeal urinary diversion of benefit
06 Jan 2022Interval between biopsy and RARP does not impact biochemical recurrence in prostate cancer
A prolonged gap between biopsy and robot-assisted radical prostatectomy (RARP) does not significantly influence the likelihood of biochemical recurrence (BCR) in prostate cancer patients, even in those who are considered high-risk, a recent Japan study has found.
Interval between biopsy and RARP does not impact biochemical recurrence in prostate cancer
28 Dec 2021Sildenafil efficacy, safety sustained regardless of delivery method
Sildenafil orally disintegrating strips (ODS) are just as effective and safe as the conventional tablet formulation for the treatment of erectile dysfunction (ED), a Thai study suggests.
Sildenafil efficacy, safety sustained regardless of delivery method
11 Dec 2021E-cigarettes raise risk of erectile dysfunction
Electronic nicotine delivery devices (ENDS) or e-cigarettes appear to be detrimental to men, with a recent study suggesting that its use contributes to a heightened risk of erectile dysfunction.
E-cigarettes raise risk of erectile dysfunction
05 Dec 2021Cisplatin-based chemotherapy boosts survival in muscle-invasive bladder cancer
Cisplatin-based adjuvant chemotherapy confers substantial survival benefit in patients with muscle-invasive bladder cancer, reports a recent meta-analysis of randomized controlled trials (RCT).